These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 22782535)
1. Synthesis and anticoagulant activity of bioisosteric sulfonic-Acid analogues of the antithrombin-binding pentasaccharide domain of heparin. Herczeg M; Lázár L; Bereczky Z; Kövér KE; Timári I; Kappelmayer J; Lipták A; Antus S; Borbás A Chemistry; 2012 Aug; 18(34):10643-52. PubMed ID: 22782535 [TBL] [Abstract][Full Text] [Related]
2. [New synthesis of the anticoagulant pentasaccharide idraparinux and preparation of its analogues containing sulfonic acid moieties]. Herczeg M Acta Pharm Hung; 2012; 82(3):113-9. PubMed ID: 23230650 [TBL] [Abstract][Full Text] [Related]
3. Toward synthesis of the isosteric sulfonate analogues of the AT-III binding domain of heparin. Herczeg M; Lázár L; Borbás A; Lipták A; Antus S Org Lett; 2009 Jun; 11(12):2619-22. PubMed ID: 19473011 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of disaccharide fragments of the AT-III binding domain of heparin and their sulfonatomethyl analogues. Herczeg M; Lázár L; Mándi A; Borbás A; Komáromi I; Lipták A; Antus S Carbohydr Res; 2011 Sep; 346(13):1827-36. PubMed ID: 21798526 [TBL] [Abstract][Full Text] [Related]
5. Antifactor Xa activity and antithrombotic activity in rats of structural analogues of the minimum antithrombin III binding sequence: discovery of compounds with a longer duration of action than of the natural pentasaccharide. Meuleman DG; Hobbelen PM; Van Dinther TG; Vogel GM; Van Boeckel CA; Moelker HC Semin Thromb Hemost; 1991; 17 Suppl 1():112-7. PubMed ID: 2068564 [TBL] [Abstract][Full Text] [Related]
6. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats. Hérault JP; Bernat A; Gaich C; Herbert M Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites. Desai UR; Petitou M; Björk I; Olson ST Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884 [TBL] [Abstract][Full Text] [Related]
8. A Modular Synthetic Approach to Isosteric Sulfonic Acid Analogues of the Anticoagulant Pentasaccharide Idraparinux. Mező E; Eszenyi D; Varga E; Herczeg M; Borbás A Molecules; 2016 Nov; 21(11):. PubMed ID: 27845725 [TBL] [Abstract][Full Text] [Related]
9. Large-scale synthesis of 6-deoxy-6-sulfonatomethyl glycosides and their application for novel synthesis of a heparinoid pentasaccharide trisulfonic acid of anticoagulant activity. Mező E; Herczeg M; Eszenyi D; Borbás A Carbohydr Res; 2014 Mar; 388():19-29. PubMed ID: 24607537 [TBL] [Abstract][Full Text] [Related]
10. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next? Petitou M; van Boeckel CA Angew Chem Int Ed Engl; 2004 Jun; 43(24):3118-33. PubMed ID: 15199558 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of conformationally locked L-iduronic acid derivatives: direct evidence for a critical role of the skew-boat 2S0 conformer in the activation of antithrombin by heparin. Das SK; Mallet JM; Esnault J; Driguez PA; Duchaussoy P; Sizun P; Herault JP; Herbert JM; Petitou M; Sinaÿ P Chemistry; 2001 Nov; 7(22):4821-34. PubMed ID: 11763451 [TBL] [Abstract][Full Text] [Related]
12. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects. Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A/ORG 31540). Petitou M; Duchaussoy P; Jaurand G; Gourvenec F; Lederman I; Strassel JM; Bârzu T; Crépon B; Hérault JP; Lormeau JC; Bernat A; Herbert JM J Med Chem; 1997 May; 40(11):1600-7. PubMed ID: 9171870 [TBL] [Abstract][Full Text] [Related]
15. From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile. Petitou M; Nancy-Portebois V; Dubreucq G; Motte V; Meuleman D; de Kort M; van Boeckel CA; Vogel GM; Wisse JA Thromb Haemost; 2009 Nov; 102(5):804-10. PubMed ID: 19888512 [TBL] [Abstract][Full Text] [Related]
16. Replacement of the L-iduronic acid unit of the anticoagulant pentasaccharide idraparinux by a 6-deoxy-L-talopyranose - Synthesis and conformational analysis. Demeter F; Gyöngyösi T; Bereczky Z; Kövér KE; Herczeg M; Borbás A Sci Rep; 2018 Sep; 8(1):13736. PubMed ID: 30213971 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of a sulfonic acid mimetic of the sulfated Lewis A pentasaccharide. Jakab Z; Fekete A; Csávás M; Borbás A; Lipták A; Antus S Carbohydr Res; 2012 Mar; 350():90-3. PubMed ID: 22300760 [TBL] [Abstract][Full Text] [Related]
18. Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans. Noti C; Seeberger PH Chem Biol; 2005 Jul; 12(7):731-56. PubMed ID: 16039522 [TBL] [Abstract][Full Text] [Related]
20. Degeneracy of the Antithrombin Binding Sequence in Heparin: 2-O-Sulfated Iduronic Acid Can Replace the Critical Glucuronic Acid. Elli S; Stancanelli E; Wang Z; Petitou M; Liu J; Guerrini M Chemistry; 2020 Sep; 26(51):11814-11818. PubMed ID: 32515841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]